Children News and Research

RSS

Inside the high-stakes corporate fight over feeding preterm babies

In 2013, a scientist at Abbott Laboratories saw study results with potentially big implications for the company's profits and the lives of some of the world's most fragile people: preterm infants.

30 Mar 2026

Short bursts of vigorous activity can lower risk of major diseases

People who get just a few minutes of vigorous activity daily are less likely to develop eight major diseases, including arthritis, heart disease and dementia, according to research published in the European Heart Journal today (Monday).

29 Mar 2026

Trial shows mavacamten benefits adolescents with obstructive heart condition

Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow tract (LVOT) gradient, a measure of blood flow obstruction in the heart, compared with those who received a placebo, according to a small study presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

29 Mar 2026

Hypercortisolism found in many patients with resistant hypertension

The MOMENTUM study found 27 percent of patients with resistant hypertension have hypercortisolism. This is a significant finding, demonstrating that hypercortisolism is more common in these patients than previously understood by researchers and clinicians.

28 Mar 2026

Microaxial flow pump fails to reduce heart damage in STEMI trial

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

28 Mar 2026

Children redefine what makes play meaningful and enjoyable

Play is critical for kids’ development — but ‘play’ in research is often defined by adult scientists, not the children themselves.

28 Mar 2026

AI helps identify childhood cancer survivors needing extra support

Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support - and the more information included in AI prompting, the better its performance.

27 Mar 2026

FDA approves first gene therapy for rare pediatric immune disorder

Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.

27 Mar 2026

FDA’s proposed food label not as effective as warning-style designs

The efficacy of front-of-package labels varies; Multi-High-In shows superior results in promoting healthier food choices compared to FDA's Nutrition Info Box.

27 Mar 2026

New initiative aims to scale individualized therapies for rare diseases

Critical Path Institute (C-Path) today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative to enable scalable development of advanced therapies for highly individualized conditions.

26 Mar 2026

Obesity-driven organ enlargement may boost cancer risk

Scientists at City of Hope® and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining excess weight increases your risk of cancer.

26 Mar 2026

Men show major gaps in male fertility knowledge, study finds

A study of 156 adult men found that knowledge about male fertility was generally low across both medical and lifestyle-related topics, with only 5 of 25 questions answered correctly by most respondents. Older men, those with a medical background, and those with suspected or treated infertility tended to score higher, while supplement use was common despite limited fertility literacy.

26 Mar 2026

Long ADHD wait times leave families feeling powerless and 'forever in limbo'

Families are feeling stressed, powerless and 'forever in limbo' as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study.

26 Mar 2026

Experts establish standardized protocols for pediatric recurrent wheezing diagnosis

Recurrent wheezing, a respiratory disorder, is caused by the narrowing of the airways, mainly affecting children aged less than 5 years.

26 Mar 2026

New fathers face delayed mental health risks after childbirth

Paternal mental health risks increase after childbirth, with delayed detection of psychiatric disorders underscoring the need for targeted support for fathers.

26 Mar 2026

Scientists discover how brain development programs fuel pediatric tumors

A team of researchers at Baylor College of Medicine, St. Jude Children's Research Hospital, Texas Children's Hospital, and collaborating institutions reveals in the journal Nature a novel mechanism that drives the development of pediatric supratentorial ependymoma (EPN), the third most common pediatric brain tumor. The findings suggest potential new approaches to treat these aggressive and chemo-resistant tumors.

26 Mar 2026

The lifelong cardiovascular impact of placental abruption

Rutgers Health research shows the risk of developing early cardiovascular disease or dying from cardiovascular disease by the age of 28 was 4.6 times higher among people born to mothers who had a placental abruption during their pregnancy.

26 Mar 2026

Study links androgens to aggressive childhood brain tumor growth

An international team led by researchers at Baylor College of Medicine, Texas Children's Hospital, McGill University and University of Pittsburgh School of Medicine has discovered what drives the growth of a lethal pediatric brain tumor called Posterior Fossa Type A (PFA) ependymoma.

25 Mar 2026

New brain atlas reveals how the human neocortex forms over time

In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and the brain later in life, investigators at Johns Hopkins Medicine and colleagues throughout the world have been mapping the molecular construction of the human brain.

25 Mar 2026

Childhood ADHD medication shows protective effect against future psychosis

A major new study, led by scientists at University College Dublin and the University of Edinburgh and funded by the St John of God Research Foundation, has found that commonly prescribed attention deficit hyperactivity disorder (ADHD) medication in childhood may lower the long‑term risk of developing serious psychotic disorders, including schizophrenia.

25 Mar 2026